COMPANY

NeuroVision Imaging

HQ: Sacramento, CA source · neurovision.com ↗ · West Coast

Keywords: diagnostics Mild Cognitive Impairment Alzheimer Disease

Location: Sacramento, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Apr 24, 2024 Trial start —: Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT06400368	Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease	Not listed	Unknown status (ClinicalTrials.gov)	Apr 24, 2024	2026-04 (estimated)

Annual award amounts. Total $151K.

Jul 3, 2013 NIH award 1R41AG044897-01 FY2013: $150,874 awarded for that fiscal year; activity R41 (STTR); PI KORONYO-HAMAOUI, MAYA; recipient as written: NEUROVISION IMAGING, LLC, SACRAMENTO, CA. A noninvasive optical imaging of source ↗